CMP as on 02-Mar-21 15:59₹ 4,404.70
Turnover (lac)₹ 80,944
Prev. Close₹ 4,453.40
Day's Vol (shares)₹ 18,37,678
Day's Range (₹)
CMP as on02-Mar-21 15:55₹ 4,406.20
Turnover (lac)₹ 2,203
Prev. Close₹ 4,453.30
Day's Vol (shares)₹ 47,382
CMP as on 02-Mar-21 0:00₹ 4,439.00
Open Interest(Contracts)₹ 37,05,375
Day's Vol (shares)₹ 17,72,875
Day's Range (Ex.Dt. 25 Mar 2021)
13:45 IST, Mar 02
DR Reddys Lab was the lone laggard in the sector, shedding ~1% at Rs4,410.95 per piece.
18:51 IST, Mar 01
Dr Reddys Laboratories allots 2,253 equity shares under ESOP
11:40 IST, Feb 26
Banking stocks were the worst hit along with substantial downside in IT, auto and financial stocks.
15:38 IST, Feb 22
Nifty Pharma index closed ~3% lower with the stocks like Aurobindo Pharma, Sun Pharma, Lupin & Dr Reddys adding fresh short positio
14:38 IST, Feb 22
Dr Reddys launches Lansoprazole DR Orally Disintegrating Tablets in U.S.
11:55 IST, Feb 22
The drug major on Monday announced the launch of lansoprazole DR orally disintegrating tablets in the US market.
11:48 IST, Feb 22
Dr. Reddys Lansoprazole DR Orally Disintegrating Tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100 (10 x 10
17:01 IST, Feb 19
Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete b
15:49 IST, Feb 19
Market breadth ended in the favour of the declines with the advance/decline ratio closing at 1:2x.
15:21 IST, Feb 19
Dr Reddys Laboratories rose 1.12% to Rs 4669.40 after the company announced that it has initiated process for emergency use authorizati